Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip Hay

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Journal of Virological Methods|August 1, 2006
Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from London: comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v1.5, and LCx HIV RNA Quantitative assaysPriscilla Swanson, Vera Holzmayer, Shihai Huang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2010
Is Mycoplasma genitalium in women the "New Chlamydia?" A community-based prospective cohort studyPippa Oakeshott, Adamma Aghaizu, Phillip Hay, et al.
Sexually Transmitted Infections|January 24, 2015
Performance evaluation of automated urine microscopy as a rapid, non-invasive approach for the diagnosis of non-gonococcal urethritisMarcus J Pond, Achyuta V Nori, Sheel Patel, et al.
Sexually Transmitted Infections|February 5, 2017
Impact of deploying multiple point-of-care tests with a 'sample first' approach on a sexual health clinical care pathway. A service evaluationEmma M Harding-Esch, Achyuta V Nori, Aseel Hegazi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2008
Safety, tolerability, and preliminary efficacy of 48 weeks of etravirine therapy in a phase IIb dose-ranging study involving treatment-experienced patients with HIV-1 infectionJulio Montaner, Patrick Yeni, Nathan N Clumeck, et al.
Frontiers in Cellular and Infection Microbiology|September 26, 2022
Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinionGilbert Donders, István Oszkár Sziller, Jorma Paavonen, et al.
Antiviral Therapy|March 6, 2012
A randomized comparative 96-week trial of boosted atazanavir versus continued boosted protease inhibitor in HIV-1 patients with abdominal adiposityGraeme J Moyle, Jaime Andrade-Villanueva, Pierre-Marie Girard, et al.
Sexually Transmitted Infections|September 5, 2020
Human papillomavirus (HPV) vaccination and oropharyngeal HPV in ethnically diverse, sexually active adolescents: community-based cross-sectional studySarah Kerry-Barnard, Simon Beddows, Fiona Reid, et al.
AIDS (London, England)|December 20, 2003
Drug resistance is uncommon in pregnant women with low viral loads taking zidovudine monotherapy to prevent perinatal HIV transmissionNick Larbalestier, Jane Mullen, Siobhan O'Shea, et al.
The Journal of Allergy and Clinical Immunology|August 9, 2015
Host, disease, and antiretroviral factors are associated with normalization of the CD4:CD8 ratio after initiating antiretroviral therapyAlan Winston, Sophie Jose, Martin Fisher, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of Virological Methods|August 1, 2006
Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from London: comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v1.5, and LCx HIV RNA Quantitative assaysPriscilla Swanson, Vera Holzmayer, Shihai Huang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2010
Is Mycoplasma genitalium in women the "New Chlamydia?" A community-based prospective cohort studyPippa Oakeshott, Adamma Aghaizu, Phillip Hay, et al.
Sexually Transmitted Infections|January 24, 2015
Performance evaluation of automated urine microscopy as a rapid, non-invasive approach for the diagnosis of non-gonococcal urethritisMarcus J Pond, Achyuta V Nori, Sheel Patel, et al.
Sexually Transmitted Infections|February 5, 2017
Impact of deploying multiple point-of-care tests with a 'sample first' approach on a sexual health clinical care pathway. A service evaluationEmma M Harding-Esch, Achyuta V Nori, Aseel Hegazi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2008
Safety, tolerability, and preliminary efficacy of 48 weeks of etravirine therapy in a phase IIb dose-ranging study involving treatment-experienced patients with HIV-1 infectionJulio Montaner, Patrick Yeni, Nathan N Clumeck, et al.
Frontiers in Cellular and Infection Microbiology|September 26, 2022
Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinionGilbert Donders, István Oszkár Sziller, Jorma Paavonen, et al.
Antiviral Therapy|March 6, 2012
A randomized comparative 96-week trial of boosted atazanavir versus continued boosted protease inhibitor in HIV-1 patients with abdominal adiposityGraeme J Moyle, Jaime Andrade-Villanueva, Pierre-Marie Girard, et al.
Sexually Transmitted Infections|September 5, 2020
Human papillomavirus (HPV) vaccination and oropharyngeal HPV in ethnically diverse, sexually active adolescents: community-based cross-sectional studySarah Kerry-Barnard, Simon Beddows, Fiona Reid, et al.
AIDS (London, England)|December 20, 2003
Drug resistance is uncommon in pregnant women with low viral loads taking zidovudine monotherapy to prevent perinatal HIV transmissionNick Larbalestier, Jane Mullen, Siobhan O'Shea, et al.
The Journal of Allergy and Clinical Immunology|August 9, 2015
Host, disease, and antiretroviral factors are associated with normalization of the CD4:CD8 ratio after initiating antiretroviral therapyAlan Winston, Sophie Jose, Martin Fisher, et al.
Pageof 6